明達醫(6527)股票可以買嗎?K線圖AI分析回答目標合理價
K線圖與股價本日交易資訊
資料日期: ,每天14:00後更新。
| 開 | 高 | 低 | 收 |
|---|---|---|---|
| 79.5 | 80 | 79.5 | 79.5 |
查看每日股價資訊表格
| 日期 | 開盤價 | 最高價 | 最低價 | 收盤價 | 成交量 |
|---|---|---|---|---|---|
| 2025/06/13 | 88.8 | 88.8 | 87.4 | 88.5 | 29 |
| 2025/06/16 | 88.5 | 89.6 | 87.6 | 87.7 | 80 |
| 2025/06/17 | 86.6 | 87.7 | 86 | 86.5 | 25 |
| 2025/06/18 | 86.5 | 86.8 | 86.5 | 86.8 | 22 |
| 2025/06/19 | 88 | 88.3 | 87.8 | 88.3 | 61 |
| 2025/06/23 | 87.9 | 88.7 | 87.9 | 88.7 | 42 |
| 2025/06/24 | 89.3 | 89.3 | 87.3 | 88.8 | 79 |
| 2025/06/25 | 88.7 | 88.7 | 88.2 | 88.6 | 13 |
| 2025/06/26 | 87.8 | 87.8 | 87 | 87.1 | 36 |
| 2025/06/27 | 87.1 | 87.3 | 87 | 87.3 | 13 |
| 2025/06/30 | 87.8 | 87.8 | 86 | 87 | 129 |
| 2025/07/01 | 87.3 | 87.3 | 86.5 | 87 | 19 |
| 2025/07/02 | 87 | 87 | 87 | 87 | 7 |
| 2025/07/03 | 87.9 | 87.9 | 86.7 | 86.7 | 24 |
| 2025/07/04 | 86.3 | 86.7 | 85.8 | 86.7 | 80 |
| 2025/07/07 | 86 | 86 | 85.6 | 85.6 | 8 |
| 2025/07/08 | 85.1 | 85.7 | 85 | 85.2 | 13 |
| 2025/07/09 | 81.9 | 85.5 | 81.9 | 85.5 | 32 |
| 2025/07/10 | 86 | 87 | 86 | 87 | 32 |
| 2025/07/11 | 87.8 | 87.8 | 87 | 87 | 3 |
| 2025/07/14 | 87 | 87 | 87 | 87 | 43 |
| 2025/07/15 | 86 | 87 | 85.9 | 87 | 56 |
| 2025/07/16 | 86.1 | 86.6 | 86.1 | 86.3 | 7 |
| 2025/07/17 | 86.3 | 86.3 | 85.8 | 85.8 | 78 |
| 2025/07/18 | 86.3 | 86.7 | 86 | 86.7 | 30 |
| 2025/07/21 | 86.5 | 86.5 | 86 | 86.5 | 15 |
| 2025/07/22 | 86.7 | 86.7 | 85.9 | 86.5 | 25 |
| 2025/07/23 | 86.5 | 88.6 | 86.5 | 88.6 | 64 |
| 2025/07/24 | 86.9 | 87.5 | 86.9 | 87.2 | 35 |
| 2025/07/25 | 87.5 | 87.6 | 87.2 | 87.3 | 25 |
| 2025/07/28 | 87 | 87.3 | 87 | 87.1 | 50 |
| 2025/07/29 | 87 | 87 | 86.5 | 87 | 38 |
| 2025/07/30 | 87 | 87 | 84.8 | 86.9 | 9 |
| 2025/07/31 | 85.3 | 85.3 | 85.3 | 85.3 | 5 |
| 2025/08/01 | 85 | 85.9 | 85 | 85.9 | 17 |
| 2025/08/04 | 86.3 | 86.3 | 85.5 | 85.6 | 9 |
| 2025/08/05 | 86.8 | 87.2 | 86 | 86.1 | 38 |
| 2025/08/06 | 86.1 | 87 | 86.1 | 86.4 | 38 |
| 2025/08/07 | 88 | 88 | 86.4 | 86.9 | 41 |
| 2025/08/08 | 86.3 | 86.9 | 86.1 | 86.9 | 26 |
| 2025/08/11 | 85.8 | 85.8 | 84.1 | 84.9 | 173 |
| 2025/08/12 | 84.9 | 86.4 | 84.8 | 86 | 24 |
| 2025/08/13 | 86 | 87 | 86 | 86 | 30 |
| 2025/08/14 | 87 | 87.2 | 86.5 | 87.2 | 35 |
| 2025/08/15 | 87 | 87.2 | 86.5 | 87.1 | 23 |
| 2025/08/18 | 87 | 87.5 | 87 | 87.5 | 169 |
| 2025/08/19 | 87.2 | 87.2 | 86.6 | 86.7 | 23 |
| 2025/08/20 | 86.5 | 86.5 | 86.3 | 86.4 | 11 |
| 2025/08/21 | 86.4 | 87.1 | 86.4 | 87.1 | 16 |
| 2025/08/22 | 86.6 | 87 | 86.6 | 86.9 | 25 |
| 2025/08/25 | 87.1 | 87.1 | 85 | 86 | 54 |
| 2025/08/26 | 86 | 86 | 86 | 86 | 21 |
| 2025/08/27 | 86.1 | 87.5 | 86 | 87.5 | 69 |
| 2025/08/28 | 87.4 | 87.5 | 87 | 87 | 35 |
| 2025/08/29 | 87 | 87.1 | 86.4 | 86.4 | 48 |
| 2025/09/01 | 87 | 87 | 86.6 | 87 | 42 |
| 2025/09/02 | 86.7 | 88 | 86.7 | 88 | 81 |
| 2025/09/03 | 88 | 88.2 | 88 | 88 | 29 |
| 2025/09/04 | 87.7 | 90.8 | 87.1 | 88.8 | 42 |
| 2025/09/05 | 88.5 | 89.4 | 88.5 | 88.6 | 29 |
| 2025/09/08 | 88.7 | 88.8 | 87.6 | 87.9 | 35 |
| 2025/09/09 | 87.6 | 88 | 86.9 | 88 | 19 |
| 2025/09/10 | 87.8 | 88.2 | 87.1 | 87.1 | 205 |
| 2025/09/11 | 87 | 87 | 86.6 | 86.6 | 12 |
| 2025/09/12 | 86.5 | 86.5 | 86 | 86.5 | 21 |
| 2025/09/15 | 86.2 | 86.2 | 86.1 | 86.1 | 7 |
| 2025/09/16 | 87.5 | 87.5 | 86 | 86 | 19 |
| 2025/09/17 | 85 | 86.1 | 85 | 86 | 107 |
| 2025/09/18 | 86 | 86.1 | 85.5 | 85.6 | 77 |
| 2025/09/19 | 85.8 | 86.5 | 85.8 | 86.5 | 13 |
| 2025/09/22 | 86.1 | 86.3 | 86 | 86.1 | 24 |
| 2025/09/23 | 85.6 | 86 | 85.3 | 86 | 8 |
| 2025/09/25 | 85.7 | 87.3 | 85.7 | 87.3 | 37 |
| 2025/09/26 | 86.3 | 86.4 | 86.1 | 86.1 | 8 |
| 2025/09/30 | 86 | 86 | 85.8 | 85.8 | 18 |
| 2025/10/01 | 85.3 | 85.5 | 85.3 | 85.5 | 5 |
| 2025/10/02 | 85.8 | 85.9 | 85.7 | 85.7 | 12 |
| 2025/10/03 | 85.3 | 86 | 85.3 | 86 | 15 |
| 2025/10/07 | 86 | 86 | 85.7 | 85.7 | 6 |
| 2025/10/08 | 85.2 | 86 | 85.2 | 86 | 25 |
| 2025/10/09 | 86 | 86.1 | 85.6 | 86.1 | 19 |
| 2025/10/13 | 85.2 | 86.1 | 84.6 | 85.2 | 16 |
| 2025/10/14 | 86.1 | 86.2 | 84.6 | 84.6 | 260 |
| 2025/10/15 | 84.6 | 85.1 | 84.6 | 85.1 | 40 |
| 2025/10/16 | 85 | 85 | 85 | 85 | 10 |
| 2025/10/17 | 83.8 | 84.3 | 83.5 | 83.9 | 261 |
| 2025/10/20 | 83.8 | 84 | 83.5 | 83.5 | 25 |
| 2025/10/21 | 83.5 | 83.5 | 83 | 83.5 | 167 |
| 2025/10/22 | 83.2 | 83.6 | 83.2 | 83.6 | 12 |
| 2025/10/23 | 83.2 | 83.6 | 83.2 | 83.2 | 20 |
| 2025/10/27 | 83.2 | 83.3 | 83 | 83.1 | 87 |
| 2025/10/28 | 83 | 83 | 82.6 | 82.6 | 11 |
| 2025/10/29 | 82.9 | 82.9 | 81.7 | 81.7 | 40 |
| 2025/10/30 | 81.8 | 81.8 | 80.8 | 80.9 | 126 |
| 2025/10/31 | 80.6 | 81.6 | 80 | 81.6 | 71 |
| 2025/11/03 | 79.1 | 81 | 79 | 81 | 40 |
| 2025/11/04 | 82 | 82.6 | 81.2 | 81.9 | 23 |
| 2025/11/05 | 81.1 | 82.3 | 81 | 82.3 | 18 |
| 2025/11/06 | 82 | 82.5 | 82 | 82 | 10 |
| 2025/11/07 | 81.5 | 82.7 | 81.5 | 82.7 | 14 |
| 2025/11/10 | 82.5 | 83.3 | 82.5 | 82.6 | 79 |
| 2025/11/11 | 82.6 | 82.6 | 82.5 | 82.5 | 20 |
| 2025/11/12 | 82.5 | 82.7 | 82.3 | 82.4 | 21 |
| 2025/11/13 | 81.9 | 81.9 | 81.8 | 81.9 | 18 |
| 2025/11/14 | 81.5 | 81.8 | 81 | 81.8 | 70 |
| 2025/11/17 | 82 | 82 | 81.5 | 81.5 | 12 |
| 2025/11/18 | 80.7 | 80.7 | 80.5 | 80.6 | 45 |
| 2025/11/19 | 80.6 | 80.6 | 80.2 | 80.2 | 36 |
| 2025/11/20 | 80.2 | 80.5 | 80.2 | 80.2 | 90 |
| 2025/11/21 | 79.7 | 79.9 | 79.1 | 79.9 | 14 |
| 2025/11/24 | 80 | 80 | 80 | 80 | 2 |
| 2025/11/25 | 80 | 80 | 79.5 | 79.8 | 25 |
| 2025/11/26 | 79.6 | 79.8 | 79.5 | 79.5 | 18 |
| 2025/11/27 | 79.3 | 79.3 | 79.3 | 79.3 | 38 |
| 2025/11/28 | 79.6 | 79.6 | 78.8 | 78.8 | 149 |
| 2025/12/01 | 78.7 | 78.7 | 78.6 | 78.6 | 96 |
| 2025/12/02 | 78.4 | 79.6 | 77.7 | 79.6 | 263 |
| 2025/12/03 | 79.5 | 79.6 | 78.3 | 79.6 | 51 |
| 2025/12/04 | 79 | 79.6 | 78.8 | 79.4 | 84 |
| 2025/12/05 | 79.5 | 80 | 79.5 | 79.5 | 26 |
AI的K線圖分析和操作建議
以下內容由AI生成:
點擊查看。AI建議自動產生於:,輸入:市場模型。 明達醫 (6527) 股價走勢分析與操作建議 綜合觀察明達…
明達醫 (6527) 股價走勢分析與操作建議
綜合觀察明達醫 (6527) 近 90 個交易日的股價走勢圖,筆者對未來數天至數週的股價趨勢判斷為持續下跌。主要理由如下:
- 下降趨勢明顯:自 2025 年 9 月下旬以來,股價呈現明顯的下降趨勢。近期(2025 年 11 月至 12 月初)股價雖有反彈,但反彈力道疲軟,且已多次觸及 MA5(5 日移動平均線)後回落,顯示短期均線壓制作用顯著。
- MA5 趨勢向下,MA20 亦呈下彎:目前 MA5 價格持續位於 MA20 之下,且兩條均線皆呈現向下趨勢,尤其 MA5 角度較為陡峭,這通常預示著空頭市場的延續。
- 近期股價表現疲軟:最近的幾個交易日(2025 年 11 月下旬至 12 月初),股價雖有小幅上漲,但收盤價均未能有效突破近期高點,且成交量並未出現明顯放大,顯示買盤力道不足,市場追價意願不高。
- 成交量柱狀圖變化:雖然有部分交易日的成交量柱狀圖較高,但其出現在股價下跌的過程中,並未能轉化為股價上漲的動能。近期成交量變化較為零散,未見持續放大的積極信號。
- 技術指標配合:股價多次挑戰 MA20 均線但未能有效突破,且短期均線(MA5)持續壓制股價,這些跡象均指向股價可能繼續向下測試支撐。
基於上述分析,預計明達醫 (6527) 在未來數天至數週的股價目標價格區間為 78 元至 81 元 。此區間是基於近期股價的低點以及 MA20 均線的相對位置所推估,並考量到市場的謹慎態度。
詳細圖表分析:
明達醫 (6527) 近 90 天股價走勢與技術指標分析 觀察期間 2025 年 9 月下旬至今(約 2025-09-20 至 2025-12-04) 整體趨勢 明顯的下降趨勢 均線分析 MA5 (5日移動平均線) MA20 (20日移動平均線) 相對位置與趨勢 持續向下 呈下彎趨勢,目前價格在 MA20 之下 MA5 位於 MA20 之下,且 MA5 壓制股價,顯示短期空頭較強。 價格行為 高點 低點 總體表現 約 88 元 (9 月下旬) 約 78 元 (12 月初) 股價自高點已下跌約 10 元,呈現明顯回調。 近期雖有反彈,但未能有效突破 MA5 或 MA20,反彈後又趨於回落。 成交量分析 成交量柱狀圖顯示,部分交易日成交量較大,但多出現在股價下跌的過程中,未能有效支持股價上漲。近期成交量變化不定,缺乏持續放大的積極訊號。 潛在支撐與壓力
- 壓力區:MA5、MA20 均線,以及近期反彈高點(約 82-83 元)。
- 支撐區:近期低點 (約 78 元),以及更低的價位。
對散戶投資人的操作建議:
針對「明達醫 (6527) 可以買嗎?」這個問題,筆者的建議是:目前不建議買入,應以觀望為主,或考慮逢高減碼。
原因如下:
- 趨勢不利:目前的股價走勢呈現明顯的下降趨勢,多項技術指標均指向空頭格局,此時介入買入的風險較高。
- 反彈力度不足:儘管股價有反彈,但力度不強,且未能有效突破關鍵的移動平均線,這顯示市場的信心尚未完全恢復。
- 潛在下跌空間:股價可能繼續下探,若在下跌趨勢中買入,可能面臨進一步的虧損。
對於已經持有該股票的散戶投資人:
- 如果投資的目的是短線操作,且股價反彈到重要的壓力區(例如 MA20 附近),可以考慮逢高減碼,降低持倉風險。
- 如果投資的目的是長線,則需要密切關注公司基本面是否有重大變化,以及整體市場環境是否有利於反轉。若基本面未見好轉,且技術面持續弱勢,則應嚴格執行停損計畫。
對於尚未持有該股票的散戶投資人:
- 強烈建議觀望。等待股價出現明確的止跌訊號,例如價穩量增、形成底部形態,或者 MA5 能夠有效上穿 MA20,並且 MA20 開始走平或向上,再考慮分批佈局。
- 若有閒置資金,可考慮將資金投入基本面較好、產業趨勢較為明朗的其他標的。
總結來說,明達醫 (6527) 目前的股價走勢顯示空頭力量較強,散戶投資人應謹慎操作,避免在不明朗的趨勢中貿然進場。
再次重申,筆者預測明達醫 (6527) 在未來數天至數週將持續下跌,目標價格區間約在 78 元至 81 元之間。建議散戶投資人目前不宜買入,以觀望為主,並適時評估減碼的可能性。
股權分散表
查看每日股權分散表表格
| 日期 | 100張以下持股比例 | 100~1000張持股比例 | 1000張以上持股比例 | 總股東人數 |
|---|---|---|---|---|
| 2024/10/04 | 37.74% | 42.95% | 19.23% | 3,022 |
| 2024/10/11 | 37.25% | 43.35% | 19.34% | 3,006 |
| 2024/10/18 | 37.05% | 43.44% | 19.43% | 2,978 |
| 2024/10/25 | 36.84% | 43.57% | 19.52% | 2,960 |
| 2024/11/01 | 36.76% | 43.65% | 19.52% | 2,949 |
| 2024/11/08 | 36.71% | 43.66% | 19.56% | 2,932 |
| 2024/11/15 | 36.53% | 43.65% | 19.75% | 2,901 |
| 2024/11/22 | 36.42% | 43.65% | 19.85% | 2,886 |
| 2024/11/29 | 36.26% | 43.66% | 20.01% | 2,868 |
| 2024/12/06 | 36.26% | 43.67% | 20.01% | 2,861 |
| 2024/12/13 | 36.25% | 43.69% | 20.01% | 2,852 |
| 2024/12/20 | 36.18% | 43.75% | 20.01% | 2,844 |
| 2024/12/27 | 36.17% | 43.76% | 20.01% | 2,834 |
| 2025/01/03 | 36.16% | 43.76% | 20.01% | 2,832 |
| 2025/01/10 | 36.09% | 43.76% | 20.08% | 2,826 |
| 2025/01/17 | 35.94% | 43.78% | 20.2% | 2,823 |
| 2025/01/22 | 35.86% | 43.79% | 20.28% | 2,812 |
| 2025/02/07 | 35.88% | 43.78% | 20.28% | 2,808 |
| 2025/02/14 | 35.86% | 43.79% | 20.28% | 2,801 |
| 2025/02/21 | 35.5% | 44.14% | 20.28% | 2,885 |
| 2025/02/27 | 35.51% | 44.15% | 20.28% | 2,866 |
| 2025/03/07 | 35.38% | 44.15% | 20.39% | 2,858 |
| 2025/03/14 | 35.34% | 44.2% | 20.39% | 2,843 |
| 2025/03/21 | 35.34% | 44.21% | 20.39% | 2,844 |
| 2025/03/28 | 34.63% | 44.92% | 20.39% | 2,843 |
| 2025/04/02 | 34.56% | 44.98% | 20.39% | 2,826 |
| 2025/04/11 | 34.75% | 44.43% | 20.77% | 2,804 |
| 2025/04/18 | 34.98% | 44.07% | 20.86% | 2,787 |
| 2025/04/25 | 34.94% | 44.05% | 20.93% | 2,787 |
| 2025/05/02 | 34.91% | 44.05% | 20.93% | 2,775 |
| 2025/05/09 | 34.91% | 44.04% | 20.97% | 2,774 |
| 2025/05/16 | 34.84% | 44.04% | 21.04% | 2,762 |
| 2025/05/23 | 34.74% | 43.43% | 21.76% | 2,758 |
| 2025/05/29 | 34.95% | 42.96% | 22% | 2,747 |
| 2025/06/06 | 34.84% | 42.96% | 22.11% | 2,739 |
| 2025/06/13 | 35.33% | 42.46% | 22.14% | 2,747 |
| 2025/06/20 | 35.18% | 42.45% | 22.29% | 2,731 |
| 2025/06/27 | 35.02% | 42.43% | 22.48% | 2,714 |
| 2025/07/04 | 34.64% | 42.39% | 22.88% | 2,702 |
| 2025/07/11 | 34.61% | 42.37% | 22.97% | 2,684 |
| 2025/07/18 | 34.94% | 41.97% | 23.02% | 2,681 |
| 2025/07/25 | 34.47% | 41.96% | 23.5% | 2,661 |
| 2025/08/01 | 34.36% | 41.94% | 23.63% | 2,673 |
| 2025/08/08 | 33.95% | 42.33% | 23.63% | 2,661 |
| 2025/08/15 | 33.76% | 42.34% | 23.82% | 2,624 |
| 2025/08/22 | 33.57% | 42.32% | 24.05% | 2,611 |
| 2025/08/29 | 33.32% | 42.25% | 24.36% | 2,587 |
| 2025/09/05 | 33.24% | 42.2% | 24.49% | 2,582 |
| 2025/09/12 | 33.1% | 42.14% | 24.69% | 2,565 |
| 2025/09/19 | 33.03% | 41.75% | 25.14% | 2,565 |
| 2025/09/26 | 32.93% | 41.69% | 25.33% | 2,554 |
| 2025/10/03 | 32.92% | 41.67% | 25.33% | 2,544 |
| 2025/10/09 | 32.87% | 41.64% | 25.42% | 2,537 |
| 2025/10/17 | 32.8% | 41.58% | 25.54% | 2,517 |
| 2025/10/23 | 32.77% | 41.61% | 25.54% | 2,497 |
| 2025/10/31 | 32.18% | 42.22% | 25.54% | 2,489 |
| 2025/11/07 | 32.2% | 42.19% | 25.54% | 2,486 |
| 2025/11/14 | 32.34% | 42.06% | 25.54% | 2,486 |
| 2025/11/21 | 32.03% | 42.38% | 25.54% | 2,483 |
| 2025/11/28 | 32.04% | 42.36% | 25.54% | 2,475 |
目前尚無評論